CORALVILLE, Iowa — — Vivakor, Inc. /quotes/comstock/11k!vivk (VIVK 0.10, -0.04, -29.08%) announced today that it has received a reseller offer agreement from VWR LLC, a multi-billion dollar global laboratory supply and distribution company, for Vivakor’s VivaThermic Vials. Vivakor’s VivaThermic vials improve cryopreservation of sensitive cell types such as human stem cells.

Vivakor ‘s Chief Executive Officer and Chief Scientific Officer, Dr. Tannin Fuja, stated, “We are very pleased to do business with VWR International LLC as this agreement has been the culmination of over six months of review and evaluation of the VivaThermic products. VWR is a premier leader in distribution of laboratory products to biotech, academic and pharmaceutical research markets.” As global demand for products supporting stem cell related markets intensifies, the potential market size for our VivaThermic vials has increased the potential revenue projections are targeted to reach in excess of $20 million annually. Dr. Fuja continued, “The estimated growth of this market will accelerate with continued private and public support for life-saving stem cell therapies and the necessary research to discover them.”

About Vivakor, Inc.

Vivakor(TM) is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds that extend or improve life. More information can be found about Vivakor at www.vivakor.com.

About VWR International LLC.

VWR International, LLC, headquartered in West Chester, Pennsylvania, is a global laboratory supply and distribution company with worldwide sales in excess of $3.5 billion in 2009. VWR enables the advancement of the world’s most critical research through the distribution of a highly diversified product line to most of the world’s top pharmaceutical and biotech companies, as well as industrial, educational and governmental organizations. With 150 years of industry experience, VWR offers a well-established distribution network that reaches thousands of specialized labs and facilities spanning the globe. VWR has 6,500 associates around the world working to streamline the way researchers across North America, Europe, and Asia stock and maintain their labs. In addition, VWR further supports its customers by providing onsite services, storeroom management, product procurement, supply chain systems integration and technical services.

For more information on VWR please visit www.vwr.com

FORWARD-LOOKING STATEMENTS

This press release may contain forward-looking statements, including, but not limited to, statements regarding Vivakor’s products and their related market potential. Forward-looking statements may be identified by the use of the words “anticipates,” “expects,” “intends,” “plans,” “should,” “could,” “would,” “may,” “will,” “believes,” “estimates,” “potential,” or “continue” and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Vivakor’s filings with the Securities and Exchange Commission, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. Vivakor undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes.

SOURCE: Vivakor, Inc.